
    
The genomic variant c.1687G>A p.Ala563Thr rs587782044 is located in the CDH1 gene, which encodes E-cadherin, a protein that plays a crucial role in cell adhesion, maintaining the integrity of epithelial cell layers, and tumor suppression. E-cadherin is a transmembrane glycoprotein that mediates calcium-dependent intercellular adhesion and is involved in mechanisms regulating cell-cell adhesions, mobility, and proliferation of epithelial cells.The specific variant c.1687G>A results in the substitution of an alanine (Ala) with a threonine (Thr) at the 563rd amino acid position of the E-cadherin protein. This missense variant is characterized by the change of a single nucleotide, which alters the coding sequence but does not lead to a loss of the entire protein. The clinical significance of this variant has been classified as uncertain in ClinVar, with a total of four submissions reporting this classification. This uncertainty may be due to a lack of definitive evidence correlating the variant with a disease phenotype or conflicting data regarding its pathogenicity.Given the role of CDH1 in tumor suppression, variants within this gene are of particular interest in the context of hereditary diffuse gastric cancer and other malignancies where E-cadherin function is critical. However, the papers provided do not discuss the variant c.1687G>A p.Ala563Thr rs587782044 in the context of the CDH1 gene or its associated phenotypes, and therefore, no specific information from these sources can be applied to the interpretation of this variant. In summary, while the variant c.1687G>A p.Ala563Thr rs587782044 in the CDH1 gene has been identified, its clinical significance remains uncertain, and further studies are needed to elucidate its impact on E-cadherin function and its potential association with disease.

ゲノム変異 c.1687G>A p.Ala563Thr rs587782044 は、CDH1遺伝子に位置しており、この遺伝子は細胞接着に重要な役割を果たし、上皮細胞層の完全性を維持し、腫瘍抑制に関与するタンパク質であるE-カドヘリンをコードしています。E-カドヘリンはカルシウム依存性の細胞間接着を媒介する膜貫通型糖タンパク質であり、細胞間接着、細胞の移動性、上皮細胞の増殖を調節するメカニズムに関与しています。

特定の変異 c.1687G>A は、E-カドヘリンタンパク質の563番目のアミノ酸位置でアラニン（Ala）がスレオニン（Thr）に置換される結果をもたらします。このミスセンス変異は、1つのヌクレオチドの変化によって特徴付けられ、コード配列を変更しますが、タンパク質全体の喪失には至りません。この変異の臨床的意義はClinVarで不確定と分類されており、この分類に関する報告は合計で4件提出されています。この不確定性は、変異と疾患表現型との明確な関連性を示す証拠が不足していることや、その病原性に関するデータが矛盾していることが原因である可能性があります。

CDH1遺伝子が腫瘍抑制に果たす役割を考慮すると、この遺伝子内の変異は、遺伝性びまん性胃癌やE-カドヘリン機能が重要な他の悪性腫瘍の文脈で特に注目されています。しかし、提供された論文では、CDH1遺伝子やその関連する表現型の文脈で変異 c.1687G>A p.Ala563Thr rs587782044 について議論されておらず、これらの情報源からこの変異の解釈に適用できる具体的な情報はありません。

まとめると、CDH1遺伝子内の変異 c.1687G>A p.Ala563Thr rs587782044 は特定されていますが、その臨床的意義は依然として不確定であり、E-カドヘリンの機能への影響や疾患との潜在的な関連性を解明するためにはさらなる研究が必要です。
    
## References
- [1] Park HJ et al. (2023). "Outstanding Characteristics of Birt-Hogg-Dube Syndrome in Korea." Diagnostics (Basel, Switzerland), 13(12) [PubMed](https://pubmed.ncbi.nlm.nih.gov/37370942/)
- [2] Paul S et al. (2024). "NAK-associated protein 1/NAP1 activates TBK1 to ensure accurate mitosis and cytokinesis." The Journal of cell biology, 223(2) [PubMed](https://pubmed.ncbi.nlm.nih.gov/38059900/)
- [3] Castelli S et al. (2021). "ROS-dependent HIF1alpha activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells." Journal of experimental & clinical cancer research : CR, 40(1) [PubMed](https://pubmed.ncbi.nlm.nih.gov/33706793/)
- [4] Benitez-Angeles M et al. (2023). "Unconventional interactions of the TRPV4 ion channel with beta-adrenergic receptor ligands." Life science alliance, 6(3) [PubMed](https://pubmed.ncbi.nlm.nih.gov/36549871/)
- [5] Dong X et al. (2020). "Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes." Communications biology, 3(1) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/31925297/)
- [6] Yang S et al. (2017). "Sources of discordance among germ-line variant classifications in ClinVar." Genetics in medicine : official journal of the American College of Medical Genetics, 19(10) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/28569743/)

    
## ClinVar Submissions
- **[RCV000130507](https://www.ncbi.nlm.nih.gov/clinvar/RCV000130507/)**: Hereditary cancer-predisposing syndrome
- **[RCV000473796](https://www.ncbi.nlm.nih.gov/clinvar/RCV000473796/)**: Hereditary diffuse gastric adenocarcinoma
- **[RCV000568401](https://www.ncbi.nlm.nih.gov/clinvar/RCV000568401/)**: Hereditary cancer-predisposing syndrome
- **[RCV000212374](https://www.ncbi.nlm.nih.gov/clinvar/RCV000212374/)**: not provided

    